(Q33759628)

English

Durable loss of a malignant T-cell clone in a stage IV cutaneous T-cell lymphoma patient treated with high-dose interferon and photopheresis

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Durable loss of a malignant T-cell clone in a stage IV cutaneous T-cell lymphoma patient treated with high-dose interferon and photopheresis (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

author name string

Haley HR

1

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Davis DA

2

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Sams WM

3

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

language of work or name

0 references

publication date

1 November 1999

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Journal of the American Academy of Dermatology

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

41

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

5 Pt 2

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

880-883

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Mycosis fungoides in the United States. Increasing incidence and descriptive epidemiology

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970351-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic factors and evaluation of mycosis fungoides and Sézary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970351-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Sézary syndrome: diagnosis, prognosis, and critical review of treatment options

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970351-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Role of interferon in regulation of cytotoxicity by natural killer cells and macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970351-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Aberrant Cytokine Production By Sezary Syndrome Patients: Cytokine Secretion Pattern Resembles Murine Th2 Cells

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970351-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Combined therapy for Sézary syndrome with extracorporeal photochemotherapy and low-dose interferon alfa therapy. Clinical, molecular, and immunologic observations

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970351-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Th2 cytokine mRNA expression in skin in cutaneous T-cell lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970351-8

7 January 2021

based on heuristic

inferred from DOI database lookup

UCLA conference. Interferon: immunobiology and clinical significance

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970351-8

7 January 2021

based on heuristic

inferred from DOI database lookup

The role of recombinant interferon alfa-2a in the therapy of cutaneous T-cell lymphomas

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970351-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Extracorporeal photopheresis and recombinant interferon alfa 2b in Sezary syndrome. Use of dual marker labeling to monitor therapeutic response

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970351-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical toxicity of interferons in cancer patients: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970351-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of cutaneous T-cell lymphoma with extracorporeal photopheresis monotherapy and in combination with recombinant interferon alfa: a 10-year experience at a single institution

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970351-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Photopheresis: a Clinically Relevant Immunobiologic Response Modifier

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970351-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Extracorporeal photochemotherapy induces the production of tumor necrosis factor-alpha by monocytes: implications for the treatment of cutaneous T-cell lymphoma and systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970351-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Mechanisms of lymphocytotoxicity induced by extracorporeal photochemotherapy for cutaneous T cell lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970351-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Proceedings of the Second International Symposium on Cutaneous T-cell Lymphoma. Chicago, Illinois, Oct. 13-17, 1993.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970351-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Review of immunomodulation by photopheresis: treatment of cutaneous T-cell lymphoma, autoimmune disease, and allograft rejection

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970351-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of erythrodermic cutaneous T-cell lymphoma with extracorporeal photochemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970351-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Histopathologic staging at initial diagnosis of mycosis fungoides and the Sézary syndrome. Definition of three distinctive prognostic groups

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970351-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0190-9622(99)70351-8

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33759628&oldid=1534179775"